You have read all your free articles, to continue reading subscribe to read the rest of this content.
QureTech Bio has received a SEK 3 million grant from the Swelife innovation programme, funded by the Swedish Government via Vinnova. “We are delighted to receive this grant, as it will enable us to create a product that can help patients and save lives,” says Fredrik Almqvist, CEO of QureTechAlready…
Farxiga (dapagliflozin) has been granted Breakthrough Therapy Designation (BTD) in the US for patients with chronic kidney disease (CKD), with and without type-2 diabetes (T2D). The Food and Drug Administration (FDA)'s BTD is designed to accelerate the development and regulatory review of potentiAlready a subscriber Login You have read all…
Alvotech has announced that its ordinary shares and warrants will begin trading on the Nasdaq Stock Market LLC on Thursday, June 16, under the new ticker symbols “ALVO” and “ALVOW”, respectively. This follows the completion of the company’s business combination with Oaktree Acquisition Already a subscriber Login You have read…
Oncopeptides has announced that the US Food and Drug Administration, FDA, has requested a withdrawal of the US marketing authorization for Pepaxto. The request is based on the outcome of the confirmatory phase 3 OCEAN study, which demonstrated an ITT overall survival HR of 1.1, but with significaAlready a subscriber…
